期刊文献+

胆管癌的免疫治疗进展 被引量:3

Progress of immunotherapy of cholangiocarcinoma
原文传递
导出
摘要 胆管癌是恶性程度高、预后差的实体肿瘤,手术切除仍然是主要治疗手段。靶向以及免疫治疗是近年来逐渐受到重视的抗肿瘤手段,尤其是免疫治疗。胆管癌的肿瘤微环境复杂,除了间质和内皮细胞外,还包括大量免疫细胞,天然和适应性免疫系统也发挥作用。本文总结了胆管癌的免疫相关研究以及最新的免疫治疗临床试验。 Cholangiocarcinoma(CCA)is a group of solid tumors with high malignant degree and poor prognosis.Surgical resection has still been the main therapy options.Targeting therapy and immunotherapy are the main anti-tumor methods that have been paid more and more attention in recent years,especially immunotherapy.The tumor microenvironment of CCA is complex,which encompasses not only interstitial and endothelial cells,but also a large number of immune cells.In addition,the innate and adaptive immune systems also play a role.This article summarizes the immune-related studies of cholangiocarcinoma and the latest clinical trials of immunotherapy.
作者 施学兵 王敬晗 姜小清 Shi Xuebing;Wang Jinghan;Jiang Xiaoqing(The First Department of Biliary Surgery,Eastern Hepatobilliary Surgery Hosipital,Naval Medical University,Shanghai 200438,China)
出处 《中华肝胆外科杂志》 CAS CSCD 北大核心 2021年第1期77-80,共4页 Chinese Journal of Hepatobiliary Surgery
关键词 胆管肿瘤 肿瘤微环境 免疫治疗 Bile duct neoplasms Tumor microenvironment Immunotherapy
  • 相关文献

参考文献3

二级参考文献32

  • 1KHAN Jamal A.,YAQIN Sharmin.Successful immunological treatment of gallbladder cancer in India―Case report[J].Journal of Zhejiang University-Science B(Biomedicine & Biotechnology),2006,7(9):719-724. 被引量:4
  • 2Koneru M,Monu N,Schaer D,Barletta J,Frey AB.Defective adhesion in tumor infiltrating CD8+ T cells.J Immunol 2006;176:6103-6111.
  • 3Waziri A,Killory B,Ogden AT 3rd,Canoll P,Anderson RC,Kent SC,Anderson DE,Bruce JN.Preferential in situ CD4+CD56+ T cell activation and expansion within human glioblastoma.J Immunol 2008; 180:7673-7680.
  • 4Takagi S,Miyagawa S,Ichikawa E,Soeda J,Miwa S,Miyagawa Y,Iijima S,Noike T,Kobayashi A,Kawasaki S.Dendritic cells,T-cell infiltration,and Grp94 expression in cholangiocellular carcinoma.Hum Pathol 2004; 35:881-886.
  • 5Kasper HU,Drebber U,Zur Hausen A,Stippel D,Dienes HP,Dries V.Dominance of CD4+ alpha/beta T-cells and inferior role of innate immune reaction in liver metastases.Anticancer Res 2003; 23:3175-3181.
  • 6Umansky V,Schirrmacher V,Rocha M.New insights into tumor-host interactions in lymphoma metastasis.J Mol Med 1996; 74:353-263.
  • 7Disis ML,Bernhard H,Jaffee EM.Use of tumour-responsive T cells as cancer treatment.Lancet 2009; 373:673-683.
  • 8Selmi C,Mackay IR,Gershwin ME.The immunological milieu of the liver.Semin Liver Dis 2007; 27:129-139.
  • 9Roayaie S,Guarrera JV,Ye MQ,Thung SN,Emre S,Fishbein TM,Guy SR,Sheiner PA,Miller CM,Schwartz ME.Aggressive surgical treatment of intrahepatic cholangiocarcinoma:predictors of outcomes.J Am Coll Surg 1998; 187:365-372.
  • 10Lieser MJ,Barry MK,Rowland C,Ilstrup DM,Nagorney DM.Surgical management of intrahepatic cholangiocarcinoma:a 31-year experience.J Hepatobiliary Pancreat Surg 1998; 5:41-47.

共引文献149

同被引文献35

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部